Potency of antihypertensive therapy with Azilsartan on Walking Activity among Peripheral Artery Disease Patients With hypertention and Intermittent Claudicatio
Not Applicable
- Conditions
- Peripheral artery disease
- Registration Number
- JPRN-UMIN000013670
- Lead Sponsor
- Sakakibara heart Institute
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 14
Inclusion Criteria
Not provided
Exclusion Criteria
1 Patient with Critical limb ischemia 2 Life expectancy 6months 3 Medication with Cablocker or At1receptor blocker 4 inappropriate patient determined from study director
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method recovery ability index(RAI) in walking exercise near infrared spectroscopy
- Secondary Outcome Measures
Name Time Method 1 absolute claudication distance, exercise time and Deoxygenated hemoglobin recovery time in walking exercise near infrared spectroscopy. WIQ score. 2 Anckle Brachial pressure Index,Pulse Wave Verocity,flow mediated vasodilatation,LF/HF in holter ECG, meanHR in holter ECG. 3 Blood pressure in Examination room. Mean blood pressure and Blood Pressure Type in 24hr. Ambulatory Blood Pressure Measurement. 4 Myocardial infarction, stroke and acute heart failure required hospitalization. 5 Adverse event of drug